CALB (03931) Acquires Additional 8.3155% Stake in Wuhan Subsidiary, Raising Ownership to 59.3155%

Stock News2025-12-24

CALB (03931) announced that on December 23, 2025, the company successfully bid for the target equity offered for sale in a public tender held at the Beijing Equity Exchange. Subsequently, on December 24, 2025, CALB entered into an equity transfer agreement with the seller, agreeing to acquire the target equity for RMB 660 million. The company has received the "State-Owned Asset Transaction Certificate" issued by the Beijing Equity Exchange for this acquisition as of December 24, 2025.

Prior to this transaction, CALB and the seller held 51% and 49% stakes in the target company, respectively. Upon completion of the acquisition, CALB's ownership in the subsidiary will increase from 51% to 59.3155%, while the target company will remain a non-wholly owned subsidiary.

The Wuhan subsidiary has demonstrated efficient production line construction and stable revenue growth since its establishment, with sound profitability and manageable debt-to-asset ratios. Based on positive growth expectations for the Wuhan subsidiary, CALB participated in the public tender. This acquisition will further strengthen the company's stake in its Wuhan operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment